U87MG cell

SKU:BHC11100464
Featured Bulk Pricing Research Validated
Overview
Click light‑blue chips for details

U87MG cell is a cell line derived from Caucasian (Male). It is commonly used as an in vitro model for 1 research. Growth characteristics: Adherent, Epithelial-like. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Human
Disease model Glioblastoma
Morphology Epithelial-like
Growth Properties Adherent
Tissue Brain
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Options selector
Catalog no. Size
300367 1 cryovial
Field Specification
Species Human
The U87MG cell line, established from a human glioblastoma, is one of the most widely utilized cellular models in neurobiological and cancer research. Originating from a malignant tumor of the central nervous system, these cells exhibit many of the hallmark features of glioblastoma multiforme (GBM), including rapid proliferation, high invasiveness, and significant genetic and phenotypic heterogeneity. This makes the U87MG cell line, also referred to as U87 cells, an invaluable tool for exploring the molecular and cellular mechanisms underlying brain tumors, as well as for testing potential therapeutic strategies. In neuroscience and immuno-oncology research, U87MG cells serve as a model to elucidate the cell function and cytotoxicity mechanisms in glioblastoma, including the exploration of NK cell cytotoxicity. The expression of NKG2D ligands on U87 cells and the use of NKG2D antibodies in studies highlight the intricate dynamics between cancer cells and the immune system, particularly NK cells, in the tumor microenvironment. The stemness features of U87 glioblastoma cells, alongside their genetic and phenotypic attributes, are subjects of intense study, aiming to unravel the mechanisms that confer these cells a high degree of plasticity and resistance to conventional therapies. The U87 cell line's exact origin remains somewhat enigmatic, with genetic analyses revealing differences from the original tumor. In summary, the U87 cell line remains a fundamental tool in glioblastoma research, facilitating a deeper understanding of the disease's biology and the quest for more effective treatments.

SKU:BHC11100464

  • Isoenzymes: Me-2, 1, PGM3, 1, PGM1, 2, ES-D, 1, AK-1, 1, GLO-1, 1, G6PD, B
  • Tumorigenic: Yes, in nude mice inoculated subcutaneously with 107 cells
  • cultureMedium: EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a)
  • supplements: Supplement the medium with 10% FBS and 1% NEAA
  • dissociationReagent: Accutase
  • subculturing: Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
  • seedingDensity: 4 x 104 cells/cm2
  • freezeMedium: As a cryopreservation medium, use 50% basal medium + 40% FBS + 10% DMSO, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
  1. Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylationAmino Acids| DOI: 10.1007/s00726-014-1857-1 | PMID: 25362567 | PMC: pmc04282698
  2. Proliferation and Cluster Analysis of Neurons and Glial Cell Organization on Nanocolumnar TiN SubstratesInternational Journal of Molecular Sciences| DOI: 10.3390/ijms21176249 | PMID: 32872379 | PMC: pmc07503702
  3. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastropheCell Death & Disease| DOI: 10.1038/cddis.2014.412 | PMID: 25275596 | PMC: pmc04237242
  4. Deep tissue optoacoustic monitoring of photothermal treatments in the NIR-II assisted with silica-coated gold nanorodsnpj Imaging| DOI: 10.1038/s44303-025-00134-7 | PMID: 41606100 | PMC: pmc12852917
  5. Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expressionCell Death & Disease| DOI: 10.1038/s41419-022-04751-7 | PMID: 35365623 | PMC: pmc08975953
  6. Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor OriginCancers| DOI: 10.3390/cancers11122028 | PMID: 31888244 | PMC: pmc06966450
  7. Laminin Adsorption and Adhesion of Neurons and Glial Cells on Carbon Implanted Titania Nanotube Scaffolds for Neural Implant ApplicationsNanomaterials| DOI: 10.3390/nano12213858 | PMID: 36364633 | PMC: pmc09656521
  8. Fever-Range Hyperthermia vs. Hypothermia Effect on Cancer Cell Viability, Proliferation and HSP90 ExpressionPLoS ONE| DOI: 10.1371/journal.pone.0116021 | PMID: 25635828 | PMC: pmc04312095
  9. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cellsOncotarget| PMID: 26008966 | PMC: pmc04558164
  10. ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway StatusCancers| DOI: 10.3390/cancers13153803 | PMID: 34359707 | PMC: pmc08345062
  11. Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in GlioblastomaScientific Reports| DOI: 10.1038/s41598-017-14495-6 | PMID: 29075041 | PMC: pmc05658376
  12. Human Microglia Extracellular Vesicles Derived from Different Microglia Cell Lines: Similarities and DifferencesACS Omega| DOI: 10.1021/acsomega.2c00816 | PMC: pmc09280972
  13. Gold Nanoparticles Enhance Radiosensitivity in Glioblastoma CellsACS Omega| DOI: 10.1021/acsomega.6c00540 | PMC: pmc13044645
  14. The Longevity-Associated Variant of BPIFB4 Reduces Senescence in Glioma Cells and in Patients’ Lymphocytes Favoring Chemotherapy EfficacyCells| DOI: 10.3390/cells11020294 | PMID: 35053408 | PMC: pmc08774353
  15. Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.Cytotherapy| DOI: 10.1016/j.jcyt.2019.03.002 | PMID: 30975602 | PMC: pm30975602
  16. Assessing the potential of bacterial signal peptides for radiopharmaceutical applications.Scientific reports| DOI: 10.1038/s41598-025-18831-z | PMID: 40940450 | PMC: pm40940450
  17. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages.Acta neuropathologica communications| DOI: 10.1186/s40478-023-01651-5 | PMID: 37697350 | PMC: pm37697350
  18. New insights into the anticancer activity of carnosol: p53 reactivation in the U87MG human glioblastoma cell line.The international journal of biochemistry & cell biology| DOI: 10.1016/j.biocel.2016.02.019 | PMID: 26939786 | PMC: pm26939786
  19. Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA MethyltransferasesFrontiers in Pharmacology| DOI: 10.3389/fphar.2022.815646 | PMID: 35559231 | PMC: pmc09086827
  20. Oncogenic relevant defensins: expression pattern and proliferation characteristics of human tumor cell lines.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine| DOI: 10.1007/s13277-015-4701-7 | PMID: 26711780 | PMC: pm26711780
  21. PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKTFrontiers in Cellular Neuroscience| DOI: 10.3389/fncel.2018.00099 | PMID: 29692710 | PMC: pmc05902688
  22. Functional Surfaces Constructed with Hyperbranched Copolymers as Optical Imaging and Electrochemical Cell Sensing PlatformsMacromolecular Chemistry and Physics| DOI: 10.1002/macp.201700433 | PMC: 10__1002_slash_macp__201700433
  23. PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanismCell Death & Disease| DOI: 10.1038/s41419-018-1293-3 | PMID: 30718520 | PMC: pmc06362213
  24. Glioblastoma Cells Counteract PARP Inhibition through Pro-Survival Induction of Lipid Droplets Synthesis and UtilizationCancers| DOI: 10.3390/cancers14030726 | PMID: 35158994 | PMC: pmc08833394
  25. Neuronal and glial cell co-culture organization and impedance spectroscopy on nanocolumnar TiN films for lab-on-a-chip devices.Biomaterials science| DOI: 10.1039/d2bm01066f | PMID: 36039696 | PMC: pm36039696
  26. Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 InhibitorPLoS ONE| DOI: 10.1371/journal.pone.0072281 | PMID: 23977270 | PMC: pmc03747081
  27. Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells.ACS chemical neuroscience| DOI: 10.1021/acschemneuro.7b00023 | PMID: 28368610 | PMC: pm28368610
  28. A Zebrafish Live Imaging Model Reveals Differential Responses of Microglia Toward Glioblastoma Cells In VivoZebrafish| DOI: 10.1089/zeb.2016.1339 | PMID: 27779463 | PMC: pmc05124743
  29. Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockersAutophagy| DOI: 10.1080/15548627.2017.1423439 | PMID: 29313411 | PMC: pmc05959333
  30. Polyphenolic Compounds of Crataegus Berry, Leaf, and Flower Extracts Affect Viability and Invasive Potential of Human Glioblastoma CellsMolecules| DOI: 10.3390/molecules26092656 | PMID: 34062758 | PMC: pmc08124274
  31. NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity.Bioorganic chemistry| DOI: 10.1016/j.bioorg.2019.103449 | PMID: 32057422 | PMC: pm32057422
  32. Antitumoral Activity of the Universal Methyl Donor S -Adenosylmethionine in Glioblastoma CellsMolecules| PMID: 38675528 | PMC: pmc11052366
  33. Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell PhenotypeFrontiers in Oncology| DOI: 10.3389/fonc.2022.933746 | PMC: pmc09355724
  34. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P.Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine| DOI: 10.1016/j.apradiso.2014.06.003 | PMID: 24973465 | PMC: pm24973465
  35. Large-scale super-resolution optoacoustic imaging facilitated by FeNP/ICG-loaded coreless polyelectrolyte microcapsulesTheranostics| DOI: 10.7150/thno.112050 | PMC: pmc12160020
  36. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides.Nature biotechnology| DOI: 10.1038/s41587-019-0013-6 | PMID: 30692694 | PMC: pm30692694
  37. Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery.Biomaterials| DOI: 10.1016/j.biomaterials.2019.119373 | PMID: 31374479 | PMC: pm31374479
  38. Human Microglia Extracellular Vesicles Derived from Different Microglia Cell Lines: Similarities and Differences.ACS omega| DOI: 10.1021/acsomega.2c00816 | PMID: 35847267 | PMC: pm35847267
  39. Using Light for Therapy of Glioblastoma Multiforme (GBM)Brain Sciences| DOI: 10.3390/brainsci10020075 | PMID: 32024010 | PMC: pmc07071600
  40. A multi-functional fluorescent scaffold as a multi-colour probe: design and application in targeted cell imagingRSC Advances| DOI: 10.1039/c5ra16600d | PMC: 10__1039_slash_c5ra16600d
  41. Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.International journal of cancer| DOI: 10.1002/ijc.30505 | PMID: 27813087 | PMC: pm27813087
  42. N 6 -Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 ExpressionFrontiers in Oncology| DOI: 10.3389/fonc.2019.01498 | PMID: 31993371 | PMC: pmc06971108
  43. Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and deathScientific Reports| DOI: 10.1038/srep15556 | PMID: 26494310 | PMC: pmc04616042
  44. Origin of the U87MG glioma cell line: Good news and bad news.Science translational medicine| DOI: 10.1126/scitranslmed.aaf6853 | PMID: 27582061 | PMC: pm27582061

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Supplier Ads Slides show

Add dynamic ads with slider